J&J says its lung cancer drug combination keeps people alive longer
Johnson & Johnson said its lung cancer regimen – Rybrevant plus Lazcluze – keeps people alive for at least a year longer than AstraZeneca's Tagrisso.
Johnson & Johnson said its lung cancer regimen – Rybrevant plus Lazcluze – keeps people alive for at least a year longer than AstraZeneca's Tagrisso.
The restaurant company, which also includes Einstein Bros. and Caribou Coffee, has been attempting to go public over the last few years.
True Religion, the Y2K-era jeans brand in the midst of a comeback, has been acquired by private equity firm ACON Investments and its partner SB360...
The ISM services survey's prices index jumped to 64.4%, an increase of 6.2 points or more than 10%.
I am a teacher at heart, and every year, for more than two decades, I have invited people to join me in the classes that...
I am a teacher at heart, and every year, for more than two decades, I have invited people to join me in the classes that...
The holiday e-commerce results from Adobe are a promising sign for the retail industry, which will begin reporting holiday results in February.
With Barr's resignation, a more precise image of incoming bank deregulation is forming.
I am a teacher at heart, and every year, for more than two decades, I have invited people to join me in the classes that...